Pre-transfusion hemoglobin (PT-Hb) levels in erythropoiesis-stimulating agent (ESA)-treated patients with chemotherapy-induced anemia (CIA): Results from randomized controlled trial (RCT) and observational data.

Elizabeth Apgar,Tanya Burton,Kay M. Larholt,Chris L. Pashos,David H. Henry,W. Langholff,Lorie Ellis,Rs Mckenzie,Mekré Senbetta,Catherine Tak Piech

Pre-transfusion hemoglobin (PT-Hb) levels in erythropoiesis-stimulating agent (ESA)-treated patients with chemotherapy-induced anemia (CIA): Results from randomized controlled trial (RCT) and observational data.

2010

Elizabeth Apgar
Tanya Burton
Kay M. Larholt
Chris L. Pashos
David H. Henry
W. Langholff
Lorie Ellis
Rs Mckenzie
Mekré Senbetta
Catherine Tak Piech

e16559 Background: Cancer patients often experience CIA and may be treated with ESAs. Recent observational data on PT-Hb levels in ESA-treated patients with CIA have not been reported. This analysi...

Keywords:

Randomized controlled trial
Physical therapy
Observational study
Anemia
Hemoglobin
Erythropoiesis-stimulating agent
Pre transfusion
Chemotherapy
Medicine
chemotherapy induced anemia
Cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations